Abstract：Objective To explore the relationship between atherogenic index of plasma (AIP) and childhood asthma. Methods This retrospective study included 86 children with asthma admitted to the Changzhou Second People's Hospital Affiliated to Nanjing Medical University from July 2020 to August 2022 as the asthma group and 149 healthy children undergoing physical examination during the same period as the control group. Metabolic parameters including total cholesterol, triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and blood glucose, as well as general information of the children such as height, weight, body mass index, presence of specific dermatitis, history of inhalant allergen hypersensitivity, family history of asthma, and feeding history, were collected. Multivariable logistic regression analysis was used to study the relationship between AIP, triglycerides, and high-density lipoprotein cholesterol and asthma. The value of AIP, triglycerides, and high-density lipoprotein cholesterol for predicting asthma was assessed using receiver operating characteristic (ROC) curve analysis. Results The AIP and triglyceride levels in the asthma group were significantly higher than those in the control group, while high-density lipoprotein cholesterol was significantly lower (P<0.05). However, there was no significant difference in total cholesterol and low-density lipoprotein cholesterol between the two groups (P>0.05). Before and after adjusting for height, weight, presence of specific dermatitis, history of inhalant allergen hypersensitivity, family history of asthma, feeding method, and blood glucose, multivariable logistic regression analysis showed that AIP, triglycerides, and high-density lipoprotein cholesterol were associated with asthma (P<0.05). ROC curve analysis showed that the optimal cutoff value for predicting asthma with AIP was -0.333, with a sensitivity of 80.2%, specificity of 55.0%, positive predictive value of 50.71%, and negative predictive value of 82.85%. The area under the curve (AUC) for AIP in predicting asthma was significantly higher than that for triglycerides (P=0.009), but there was no significant difference in AUC between AIP and high-density lipoprotein cholesterol (P=0.686). Conclusions AIP, triglycerides, and high-density lipoprotein cholesterol are all associated with asthma. AIP has a higher value for predicting asthma than triglycerides and comparable value to high-density lipoprotein cholesterol.
2 Global Initiative for Asthma. Global strategy for asthma management and prevention (update 2021)[EB/OL]. [2022-03-29]. https://ginasthma.org/wp-content/uploads/2021/05/GINA-Main-Report-2021-V2-WMS.pdf.
Peng J, Huang Y. Meta-analysis of the association between asthma and serum levels of high-density lipoprotein cholesterol and low-density lipoprotein cholesterol[J]. Ann Allergy Asthma Immunol, 2017, 118(1): 61-65. PMID: 27839668. DOI: 10.1016/j.anai.2016.09.447.
Tang Z, Shen M, Xiao Y, et al. Association between atopic dermatitis, asthma, and serum lipids: a UK biobank based observational study and mendelian randomization analysis[J]. Front Med (Lausanne), 2022, 9: 810092. PMID: 35265637. PMCID: PMC8899503. DOI: 10.3389/fmed.2022.810092.
Dobiásová M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma [FER(HDL)][J]. Clin Biochem, 2001, 34(7): 583-588. PMID: 11738396. DOI: 10.1016/s0009-9120(01)00263-6.
Zhu X, Yu L, Zhou H, et al. Atherogenic index of plasma is a novel and better biomarker associated with obesity: a population-based cross-sectional study in China[J]. Lipids Health Dis, 2018, 17(1): 37. PMID: 29506577. PMCID: PMC5836428. DOI: 10.1186/s12944-018-0686-8.
Kucera M, Oravec S, Hirnerova E, et al. Effect of atorvastatin on low-density lipoprotein subpopulations and comparison between indicators of plasma atherogenicity: a pilot study[J]. Angiology, 2014, 65(9): 794-799. PMID: 24163116. DOI: 10.1177/0003319713507476.
Bloom CI, Franklin C, Bush A, et al. Burden of preschool wheeze and progression to asthma in the UK: Population-based cohort 2007 to 2017[J]. J Allergy Clin Immunol, 2021, 147(5): 1949-1958. PMID: 33453287. DOI: 10.1016/j.jaci.2020.12.643.
Zhao L, Yang Y, Zang YR, et al. Risk factors for asthma in patients with allergic rhinitis in eastern China[J]. Am J Otolaryngol, 2022, 43(3): 103426. PMID: 35460970. DOI: 10.1016/j.amjoto.2022.103426.
Barochia AV, Gordon EM, Kaler M, et al. High density lipoproteins and type 2 inflammatory biomarkers are negatively correlated in atopic asthmatics[J]. J Lipid Res, 2017, 58(8): 1713-1721. PMID: 28655726. PMCID: PMC5538292. DOI: 10.1194/jlr.P077776.
Su X, Ren Y, Li M, et al. Association between lipid profile and the prevalence of asthma: a meta-analysis and systemic review[J]. Curr Med Res Opin, 2018, 34(3): 423-433. PMID: 28945108. DOI: 10.1080/03007995.2017.1384371.
Jiang T, Dai L, Li P, et al. Lipid metabolism and identification of biomarkers in asthma by lipidomic analysis[J]. Biochim Biophys Acta Mol Cell Biol Lipids, 2021, 1866(2): 158853. PMID: 33160078. DOI: 10.1016/j.bbalip.2020.158853.
Ikonen E. Cellular cholesterol trafficking and compartmentalization[J]. Nat Rev Mol Cell Biol, 2008, 9(2): 125-138. PMID: 18216769. DOI: 10.1038/nrm2336.
Karr S. Epidemiology and management of hyperlipidemia[J]. Am J Manag Care, 2017, 23(9 Suppl): S139-S148. PMID: 28978219.
Emruzi Z, Babaheidarian P, Arshad M, et al. Immune modulatory effects of hypercholesterolemia: can atorvastatin convert the detrimental effect of hypercholesterolemia on the immune system?[J]. Iran J Allergy Asthma Immunol, 2019, 18(5): 554-566. PMID: 32245299. DOI: 10.18502/ijaai.v18i5.1925.
Verduci E, Banderali G, Di Profio E, et al. Effect of individual- versus collective-based nutritional-lifestyle intervention on the atherogenic index of plasma in children with obesity: a randomized trial[J]. Nutr Metab (Lond), 2021, 18(1): 11. PMID: 33436021. PMCID: PMC7805105. DOI: 10.1186/s12986-020-00537-w.
